In COVID-19 patients, significantly higher IL-4 lung tissue expression and M2 macrophages were observed [70], and the prevalence of IL-4 Th2-mediated lung damage was a characteristic of the ineffective immune response elicited by SARS-CoV-2 [69]. The gene discussed is IL4; the disease is COVID-19.